Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
24 Corporate Circle, Albany, NY, 12203, US
Curia is a CDMO with over 30 years of experience, 20+ global sites and 3,000 employees. Our small molecules, generic APIs and biologics offerings span discovery to commercialization, with integrated regulatory and analytical capabilities. Our state-of-the-art facilities enable efficient drug manufacturing, accelerating life-changing therapeutics.
Unleashing Excellence in Quality, Supply Chain, HPAPIs & Orphan Drugs.
Released By Curia
Effective strategies to secure and de-risk pharmaceutical supply chains and how Curia assures the continual production of urgently needed drugs.
The current trend of increased potency of drug substances is driving the need for better cleaning methods to reduce cross contamination.
BioMarin adds scale of operations, including global commercial footprint and in-house manufacturing capabilities for rare diseases.
By: Kristin Brooks
Adds a Gerteis Macro-Pactor at its Whippany, NJ facility.
By: Charlie Sternberg
The site will manufacture orforglipron, Lilly's first oral, small molecule GLP-1 receptor agonist.
Carole Ho and Adrienne Brown to drive expansion plans in neuroscience and immunology.
Adds differentiated technology and data intelligence solutions aimed at faster, more informed drug development.
Will support a 40% increase in the Charles City, IA site's large-scale manufacturing capacity, reaching nearly one million liters.
Adds high purity sucrose to injectables portfolio, and highlights low nitrite pharmaceutical excipients.
Adds navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst’s HAE portfolio.
Adds potential first- and best-in-class late-stage asset for the treatment of MASH.
New facility provides end-to-end, temperature-controlled supply chain solutions under one roof.
Will enable AbbVie to relocate API production for select products from Europe and Asia to the U.S.
Appoints Sam Ricchezza as Senior Managing Advisor, Commercial Operations.
The acquisition adds Durect's lead asset, larsucosterol, to Bausch Health’s hepatology pipeline.
New suite in Sandwich, UK adds proprietary, CE-certified flow equipment.
The companies partner on antibody drug conjugates, drug substance, and drug product manufacturing services.
By: Rachel Klemovitch
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
